DEVICE FOR TUBE DISCHARGING von ZHBANTOV,GEORGI I

Volltext bestellen

Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer von Petrova, Mila P., Eneva, Mariyana I., Arabadjiev, Jeliazko I., Conev, Nikolay V., Dimitrova, Eleonora G., Koynov, Krassimir D., Karanikolova, Teodora S., Valev, Spartak S., Gencheva, Radostina B., Zhbantov, Georgi A., Ivanova, Anika I., Sarbianova, Iva I., Timcheva, Constanta V., Donev, Ivan S.

Volltext

Patient resilience and distress level prior to chemotherapy based on time estimation von Kraleva, Petya, Petrova, Mila, Popov, Teodor, Conev, Nikolay Vladimirov, Dimitrova, Eleonora, Ruseva, Rossitza Krasteva, Changalova, Aynura, Iliev, Bozhidar, Nedeva, Snezhina, Tatarov, Tsvetan, Zhbantov, Georgi, Hadjiev, Rosen, Donev, Ivan

Volltext

Comprehensive analysis of long noncoding RNA expression in circulation of breast cancer patients on neoadjuvant therapy von Krastev, Boris, Timcheva, Constanta, Valev, Spartak, Zhbantov, Georgi, Stoykov, Ivaylo, Stamenov, Georgi

Volltext

PI3KCA mutation prevalence and outcome among patients with metastatic breast cancer in Bulgaria treated with first-line endocrine therapy von Gencheva, Radostina, Hadjidekova, Savina, Petrova, Mila, Krustev, Dimo, Kraleva, Petya, Zhbantov, Georgi, Conev, Nikolay Vladimirov, Stoyanov, Dragomir Svetozarov, Arabadjiev, Jeliazko Iliev, Tazimova, Eliz, Bachurska, Svitlana, Galev, Ivan, Eneva, Mariyana, Tsvetkova, Mariela, Staneva, Rada, Dimitrova, Eleonora, Hadjiev, Rossen, Donev, Ivan

Volltext

Abstract OT1-03-03: Investigating circulating lncRNAs in breast cancer patients on neoadjuvant systemic therapy von Krastev, Boris, Timcheva, Constanta, Valev, Spartak, Zhbantov, Georgi, Petrova, Mila, Karanikolova, Teodora, Gencheva, Radostina, Ivanova, Anika, Stoykov, Ivaylo, Stamenov, Georgi

Volltext

Sarcopenia as a negative predictive marker for treatment with pembrolizumab as a second line in patients with metastatic non-small cell lung cancer von Petrova, Milla, Valchev, Gerogi, Conev, Nikolay Vladimirov, Dimitrova, Eleonora, Robev, Bozhil, Boneva, Marsella, Pavlov, Boian, Minchev, Velko, Karanikolova, Teodora, Valev, Spartak, Gencheva, Radostina, Zhbantov, Georgi, Ivanova, Anika, Timcheva, Constanta, Donev, Ivan

Volltext

High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line von Petrova, Milla, Eneva, Mariyana, Arabadjiev, Jeliazko Iliev, Conev, Nikolay Vladimirov, Dimitrova, Eleonora, Koynov, Krassimir Dimitrov, Karanikolova, Teodora, Valev, Spartak, Gencheva, Radostina, Zhbantov, Georgi, Ivanova, Anika, Sarbianova, Iva, Penkova, Polya, Timcheva, Konstanta, Donev, Ivan

Volltext

Abstract P3-02-05: Interim Analysis Results from a European Disease Registry Study Aimed to Prospectively Observe Treatment Patterns and Outcomes in Patients with HER2+ Unresectabl... von Balic, Marija, Costa, Luis, Ojaimi, Joseline, Oprean, Cristina Marinela, Coelho, José L. Passos, Pazos, Isabel, Puglisi, Fabio, Sanglier, Thibaut, Scandurra, Giuseppa, Schenker, Michael, Wahyudi, Laurentia A., Zhbantov, Georgi, Timcheva, Constanta

Volltext

Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer von Petrova, Mila P., Eneva, Mariyana I., Arabadjiev, Jeliazko I., Conev, Nikolay V., Dimitrova, Eleonora G., Koynov, Krassimir D., Karanikolova, Teodora S., Valev, Spartak S., Gencheva, Radostina B., Zhbantov, Georgi A., Ivanova, Anika I., Sarbianova, Iva I., Timcheva, Constanta V., Donev, Ivan S.

Volltext